173 related articles for article (PubMed ID: 31270029)
1. ANGPTL3 inhibits renal cell carcinoma metastasis by inhibiting VASP phosphorylation.
Zhao T; Liang X; Chen J; Bao Y; Wang A; Gan X; Lu X; Wang L
Biochem Biophys Res Commun; 2019 Aug; 516(3):880-887. PubMed ID: 31270029
[TBL] [Abstract][Full Text] [Related]
2. Angiopoietin-like protein 3 blocks nuclear import of FAK and contributes to sorafenib response.
Bao Y; Yang F; Liu B; Zhao T; Xu Z; Xiong Y; Sun S; Qu L; Wang L
Br J Cancer; 2018 Aug; 119(4):450-461. PubMed ID: 30033448
[TBL] [Abstract][Full Text] [Related]
3. ANGPTL3 Overexpression Suppresses the Development of Oncogenic Properties in Renal Cell Carcinoma via the Wnt/
Zhang YJ; Zhang L; Feng F; Cao QF
Dis Markers; 2021; 2021():2863856. PubMed ID: 34484467
[TBL] [Abstract][Full Text] [Related]
4. Ghrelin promotes renal cell carcinoma metastasis via Snail activation and is associated with poor prognosis.
Lin TC; Liu YP; Chan YC; Su CY; Lin YF; Hsu SL; Yang CS; Hsiao M
J Pathol; 2015 Sep; 237(1):50-61. PubMed ID: 25925728
[TBL] [Abstract][Full Text] [Related]
5. G3BP1 promotes tumor progression and metastasis through IL-6/G3BP1/STAT3 signaling axis in renal cell carcinomas.
Wang Y; Fu D; Chen Y; Su J; Wang Y; Li X; Zhai W; Niu Y; Yue D; Geng H
Cell Death Dis; 2018 May; 9(5):501. PubMed ID: 29717134
[TBL] [Abstract][Full Text] [Related]
6. Alterative Expression and Localization of Profilin 1/VASPpS157 and Cofilin 1/VASPpS239 Regulates Metastatic Growth and Is Modified by DHA Supplementation.
Ali M; Heyob K; Jacob NK; Rogers LK
Mol Cancer Ther; 2016 Sep; 15(9):2220-31. PubMed ID: 27496138
[TBL] [Abstract][Full Text] [Related]
7. MAGI1 mediates tumor metastasis through c-Myb/miR-520h/MAGI1 signaling pathway in renal cell carcinoma.
Wang W; Yang Y; Chen X; Shao S; Hu S; Zhang T
Apoptosis; 2019 Dec; 24(11-12):837-848. PubMed ID: 31352641
[TBL] [Abstract][Full Text] [Related]
8. Long non-coding RNA HOTAIR promotes cell migration by upregulating insulin growth factor-binding protein 2 in renal cell carcinoma.
Katayama H; Tamai K; Shibuya R; Nakamura M; Mochizuki M; Yamaguchi K; Kawamura S; Tochigi T; Sato I; Okanishi T; Sakurai K; Fujibuchi W; Arai Y; Satoh K
Sci Rep; 2017 Sep; 7(1):12016. PubMed ID: 28931862
[TBL] [Abstract][Full Text] [Related]
9. TNF‑α inhibits xenograft tumor formation by A549 lung cancer cells in nude mice via the HIF‑1α/VASP signaling pathway.
Liu W; Chen X; He Y; Tian Y; Xu L; Ma Y; Hu P; Su K; Luo Z; Wei L; Zhang J
Oncol Rep; 2019 Apr; 41(4):2418-2430. PubMed ID: 30816548
[TBL] [Abstract][Full Text] [Related]
10. GSK-3 directly regulates phospho-4EBP1 in renal cell carcinoma cell-line: an intrinsic subcellular mechanism for resistance to mTORC1 inhibition.
Ito H; Ichiyanagi O; Naito S; Bilim VN; Tomita Y; Kato T; Nagaoka A; Tsuchiya N
BMC Cancer; 2016 Jul; 16():393. PubMed ID: 27387559
[TBL] [Abstract][Full Text] [Related]
11. ERCC6L that is up-regulated in high grade of renal cell carcinoma enhances cell viability in vitro and promotes tumor growth in vivo potentially through modulating MAPK signalling pathway.
Zhang G; Yu Z; Fu S; Lv C; Dong Q; Fu C; Kong C; Zeng Y
Cancer Gene Ther; 2019 Sep; 26(9-10):323-333. PubMed ID: 30459398
[TBL] [Abstract][Full Text] [Related]
12. FSCN1 predicts survival and is regulated by a PI3K-dependent mechanism in renal cell carcinoma.
Zhang M; Zhao Z; Duan X; Chen P; Peng Z; Qiu H
J Cell Physiol; 2018 Jun; 233(6):4748-4758. PubMed ID: 29148041
[TBL] [Abstract][Full Text] [Related]
13. Wilms' tumor 1-associating protein promotes renal cell carcinoma proliferation by regulating CDK2 mRNA stability.
Tang J; Wang F; Cheng G; Si S; Sun X; Han J; Yu H; Zhang W; Lv Q; Wei JF; Yang H
J Exp Clin Cancer Res; 2018 Feb; 37(1):40. PubMed ID: 29482572
[TBL] [Abstract][Full Text] [Related]
14. MicroRNA-610 inhibits the migration and invasion of gastric cancer cells by suppressing the expression of vasodilator-stimulated phosphoprotein.
Wang J; Zhang J; Wu J; Luo D; Su K; Shi W; Liu J; Tian Y; Wei L
Eur J Cancer; 2012 Aug; 48(12):1904-13. PubMed ID: 22189055
[TBL] [Abstract][Full Text] [Related]
15. CXC chemokine receptor 4 is essential for maintenance of renal cell carcinoma-initiating cells and predicts metastasis.
Gassenmaier M; Chen D; Buchner A; Henkel L; Schiemann M; Mack B; Schendel DJ; Zimmermann W; Pohla H
Stem Cells; 2013 Aug; 31(8):1467-76. PubMed ID: 23630186
[TBL] [Abstract][Full Text] [Related]
16. Vasodilator-stimulated phosphoprotein regulates osteosarcoma cell migration.
Wu G; Wei L; Yu A; Zhang M; Qi B; Su K; Hu X; Wang J
Oncol Rep; 2011 Dec; 26(6):1609-15. PubMed ID: 21874265
[TBL] [Abstract][Full Text] [Related]
17. The kinesin motor protein KIF4A as a potential therapeutic target in renal cell carcinoma.
Liu G; Lu Y; Li L; Jiang T; Chu S; Hou P; Bai J; Chen M
Invest New Drugs; 2020 Dec; 38(6):1730-1742. PubMed ID: 32533288
[TBL] [Abstract][Full Text] [Related]
18. Pinin acts as a poor prognostic indicator for renal cell carcinoma by reducing apoptosis and promoting cell migration and invasion.
Jin M; Li D; Liu W; Wang P; Xiang Z; Liu K
J Cell Mol Med; 2021 May; 25(9):4340-4348. PubMed ID: 33811436
[TBL] [Abstract][Full Text] [Related]
19.
Lin TC
Int J Mol Sci; 2020 Apr; 21(8):. PubMed ID: 32326089
[TBL] [Abstract][Full Text] [Related]
20. Silencing of lysyl oxidase‑like 2 inhibits the migration, invasion and epithelial‑to‑mesenchymal transition of renal cell carcinoma cells through the Src/FAK signaling pathway.
Hong X; Yu JJ
Int J Oncol; 2019 May; 54(5):1676-1690. PubMed ID: 30816490
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]